Equity Issuances

Mag Magna Corp issued convertible note to Lambda Ventures, LLC for cash proceeds of $85,530.00.

“the Company issued to Lambda a convertible promissory note in the principal amount of $91,292.40 (the "Lambda Note") for cash proceeds of $85,530.00”

Mag Magna Corp issued 40,575 shares of Common Stock of warrant to Monroe Street Capital Partners, LP.

“Monroe was also issued a five-year warrant (the "Monroe Warrant") to purchase 40,575 shares of Common Stock with standard anti-dilution provisions and cashless exercise”

Mag Magna Corp issued convertible note to Monroe Street Capital Partners, LP for cash proceeds of $85,530.00.

“the Company issued to Monroe a convertible promissory note in the principal amount of $91,292.40 (the "Monroe Note") for cash proceeds of $85,530.00”

Mag Magna Corp issued 15,000 shares of Common Stock of common stock to Monroe Street Capital Partners, LP for consideration for entering into the Purchase Agreement.

“the Company agreed to issue 15,000 shares of Common Stock (the "Initial Commitment Shares") to Monroe”

VisionWave Holdings, Inc. issued 365,610 shares of common stock to SaverOne 2014 Ltd. for 148,584 restricted ADSs (representing 6,418,828,800 restricted ordinary shares) representing 19.99% of SaverOne's issued and outstanding share capital.

“of approximately $2.7 million, calculated based on the VWAV Average Price (as defined in the Exchange Agreement) of $7.5031 per share. In exchange, SaverOne issued to the Company148,584 restricted ADSs (representing 6,418,828,800 restricted ordinary shares) representing 19.99% of SaverOne's issued and outstanding share capital as of the effective date of the”

Creative Media & Community Trust Corp issued approximately 1,873,573 shares of Series A Preferred Stock, approximately 7,556,751 shares of Series A1 Preferred Stock and approximately 21,760 shares of Serie of preferred stock to holders of Preferred Stock for on March 6, 2026, the Company provided notice of the redemption.

“On March 6, 2026, the Company provided notice of the redemption of approximately 1,873,573 shares of Series A Preferred Stock, approximately 7,556,751 shares of Series A1 Preferred Stock and approximately 21,760 shares of Series D Preferred Stock, par value $0.001 (the “Series D Preferred Stock” and, together with the Series A Preferred Stock and Series A1 Preferred Stock, the “Preferred Stock”), in shares of Common Stock.”

Creative Media & Community Trust Corp issued approximately 83,450 shares of Series A Preferred Stock ... and approximately 210,858 shares of Series A1 Preferred Stock of preferred stock to holders of Preferred Stock.

“The Company expects to satisfy all redemptions of Preferred Stock (as defined below) initiated by holders prior to March 5, 2026 on March 12, 2026, which will result in the redemption of approximately 83,450 shares of Series A Preferred Stock, par value $0.001 (the “Series A Preferred Stock”), and approximately 210,858 shares of Series A1 Preferred Stock, par value $0.001 (the “Series A1 Preferred Stock”), in shares of the Company’s Common Stock, par value $0.001 (the “Common Stock”).”

SL GREEN REALTY CORP issued 252,000 Series Y Preferred Units of preferred stock for a portion of the consideration for the acquisition of ownership interests in certain commercial real estate property.

“252,000 Series Y Preferred Units have been issued as a portion of the consideration for the acquisition of ownership interests in certain commercial real estate property.”

Ares Real Estate Income Trust Inc. issued 838,347 of common stock to Class S-PR shareholders for $6,845,861 gross proceeds.

“as amended, pursuant to Regulation D. The following table details the shares issued and gross proceeds : Number of Shares Issued Gross Proceeds Class S-PR Shares (1)(2) 838,347 $ 6,845,861 Class D-PR Shares (1) 95,808 $ 775,993 Class I-PR Shares (1) 2,367,269 $ 19,179,616 _________________________ (1) Number of shares issued and gross proceeds include activity from”

ARTELO BIOSCIENCES, INC. issued common stock.

“on February 27, 2026, Artelo’s Board of Directors approved a 3-for-1 reverse stock split ("Reverse Split") of the Company’s common stock ("Common Stock").”

AMERICAN REBEL HOLDINGS INC issued 2,450,000 shares of common stock to Streeterville.

“On February 25, 2026, the Company issued Streeterville 2,450,000 shares of common stock pursuant to the exchanges set forth in Item 1.01 above.”

Blackstone Real Estate Income Trust, Inc. issued 4,234,209 shares of common stock to accredited investors for aggregate consideration of approximately $60.4 million.

“On March 2, 2026, Blackstone Real Estate Income Trust, Inc. (the “Company”) sold unregistered shares of the Company’s common stock (the “Shares”) for aggregate consideration of approximately $60.4 million.”

Solid Biosciences Inc. issued pre-funded warrants to purchase 27,807,482 shares of the Company’s common stock of warrant to Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Invus, Vestal Point Capital, Janus Henderson Investors, and Deep Track Capital, among others for $5.609 per Pre-Funded Warrant.

“On March 6, 2026, Solid Biosciences Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain institutional accredited investors (the “ Investors ”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement an aggregate of 14,973,257 shares of the Company’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $5.61 per share, and, to investors who so choose in lieu of Shares, pre-funded warrants to purchase 27,807,482 shares of the Company’s common stock (the “ Pre-Funded Warrants ”), at a price of $5.609 per Pre-Funded Warrant (the “ Private Placement ”).”

Solid Biosciences Inc. issued 14,973,257 shares of the Company’s common stock of common stock to Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Invus, Vestal Point Capital, Janus Henderson Investors, and Deep Track Capital, among others for $5.61 per share.

“On March 6, 2026, Solid Biosciences Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain institutional accredited investors (the “ Investors ”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement an aggregate of 14,973,257 shares of the Company’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $5.61 per share, and, to investors who so choose in lieu of Shares, pre-funded warrants to purchase 27,807,482 shares of the Company’s common stock (the “ Pre-Funded Warrants ”), at a price of $5.609 per Pre-Funded Warrant (the “ Private Placement ”).”

OS Therapies Inc issued up to 1,666,667 shares of warrant to accredited investors for aggregate gross proceeds of $2,000,000.

“Warrants to purchase up to 1,666,667 shares of the Company’s common stock (the “Warrant Shares”), for aggregate gross proceeds of $2,000,000”

OS Therapies Inc issued convertible note to accredited investors for aggregate gross proceeds of $2,000,000.

“principal amount of $2,200,000 and (ii) Warrants to purchase up to 1,666,667 shares of the Company’s common stock (the “Warrant Shares”), for aggregate gross proceeds of $2,000,000, before deducting placement agent fees and other Private Placement expenses. The Notes were sold at a 10% original issue discount, such that for each $100,000 invested by a”

Nuvve Holding Corp. issued 814,532 shares of Nuvve’s common stock of common stock to Oelion AB and OMNIA Group Holdings AG for aggregate value of approximately $1,018,165 as of the close of trading on March 5, 2026.

“In consideration for this, the Company has agreed to issue, subject to the accomplishment of various contractual and operational milestones, 814,532 shares of Nuvve’s common stock, par value $0.0001 per share, (the “Common Stock Consideration”), which is equivalent to approximately 19.9% of Nuvve’s outstanding Common Stock as of the date of execution of the Cooperation Agreement representing an aggregate value of approximately $1,018,165 as of the close of trading on March 5, 2026”

indie Semiconductor, Inc. issued convertible note to Deutsche Bank Securities Inc. and TD Securities (USA) LLC, as representatives of the several initial purchasers for $150,000,000 aggregate principal amount of 4.00% Convertible Senior Notes due 2031.

“On March 6, 2026, indie Semiconductor, Inc. (the “ Company ”) completed its previously announced private offering (the “ offering ”) of 4.00% Convertible Senior Notes due 2031.”

Diameter Credit Co issued 3,109,176.12 shares of common stock to certain investors for $86,943,490.05.

“thereunder. The following table details the amount of Shares sold and consideration therefor: Date of Unregistered Sale Amount of Shares Consideration March 2, 2026 3,109,176.12 $86,943,490.05 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto”

EQT Exeter Real Estate Income Trust, Inc. issued 83,445.063 Class A-II shares of common stock of common stock to accredited investors for $10.74 per share, aggregate purchase price of approximately $0.90 million.

“On March 2, 2026, the Company issued 83,445.063 Class A-II shares of common stock at a price per share of $10.74 to accredited investors in a private placement for an aggregate purchase price of approximately $0.90 million.”

Fortress Net Lease REIT issued 7,799,360 common shares of common stock for gross proceeds of approximately $81.3 million.

“On March 2, 2026, Fortress Net Lease REIT (the “Company” or “we”) issued and sold an aggregate of 7,799,360 common shares for gross proceeds of approximately $81.3 million”

Medicus Pharma Ltd. issued 4,471,038 of common stock to YA II PN, Ltd. for $3,846,910.

“the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below: Date of Sale Number of Common Shares Approximate Aggregate Consideration December 19, 2025 66,667 $113,647 December 19, 2025 5,432 $9,221 December 29, 2025 41,250 $66,149 December 29, 2025 20,909 $32,451 January 9, 2026 100,000 $150,640 January 15, 2026 33,333 $48,006 January 15, 2026 11,347 $15,960 January 29, 2026 7,100 $8,609 February 10, 2026 175,000 $186,603 February 18, 2026 250,000 $237,200 February 23, 2026 275,000 $302,088 March 5, 2026 700,000 $988,890 March 5, 2026 1,360,000 $1,047,336 March 6, 2026 1,425,000 $640,110 Total 4,471,038 $3,846,910”

Principal Credit Real Estate Income Trust issued 73,814.24 common shares of common stock to third party investors for $1,506,250.00.

“on March 2, 2026, the Company sold an aggregate of 73,814.24 common shares (the “Shares”) for aggregate consideration of approximately $1,506,250.00, to third party investors”

FORTRESS CREDIT REALTY INCOME TRUST issued 1,452,782 common shares of common stock to not specified for gross proceeds of approximately $29.2 million.

“On March 2, 2026, Fortress Credit Realty Income Trust (the “Company” or “we”) issued and sold an aggregate of 1,452,782 common shares for gross proceeds of approximately $29.2 million, based on net asset value per share of the applicable class of common shares as of January 31, 2026.”

Goldman Sachs Real Estate Finance Trust Inc issued 626,569.903 shares of Class I Common Stock exchanged for an equivalent number of shares of Class NV-2 Common Stock of common stock to existing holders of Company's securities for exchange of equivalent number of shares.

“on March 2, 2026, the Company exchanged 626,569.903 shares of its Class I Common Stock for an equivalent number of shares of its Class NV-2 Common Stock.”

Goldman Sachs Real Estate Finance Trust Inc issued 333,060.329 shares of Class I Common Stock, 138,788.970 shares of Class S Common Stock, 1,398,322.014 shares of Class NV-2 Common Stock, 998,402.556 shares of C of common stock to accredited investors for $8,336,500 for Class I Common Stock, $3,508,515 for Class S Common Stock, $35,000,000 for Class NV-2 Common Stock, $25,000,000 for Class F-II Common Stock.

“On March 2, 2026, Goldman Sachs Real Estate Finance Trust Inc (the “Company”) sold unregistered shares of its common stock (the “Shares”) pursuant to its ongoing private offering (the “Offering”).”

CID Holdco, Inc. issued 230,770 shares of warrant to J.J. Astor & Co..

“the Company issued the Lender a warrant (the “Initial Lender Warrant and together with any Additional Lender Warrants, the “Lender Warrants”) to purchase up to 230,770 shares of common stock, par value $0.0001 per share, of the Company (the “Company”) at an exercise price of $1.69 per share, subject to certain adjustments.”

Artius II Acquisition Inc. issued convertible note to Artius II Acquisition Partners LLC for aggregate principal amount of up to $1,000,000.00.

“On March 6, 2026, Artius II Acquisition Inc. (the “Company”) issued a convertible unsecured promissory note (the “Working Capital Promissory Note”) in the aggregate principal amount of up to $1,000,000.00 to Artius II Acquisition Partners LLC, a Delaware limited liability company (the “Sponsor”), in order to provide the Company with additional working capital.”

Apollo IG Core Replacement, L.P. issued securities to accredited investors for aggregate consideration of approximately $0.3 million in cash.

“Apollo IG Core Replacement, L.P. (“Apollo IG Core”) issued unregistered limited partnership interests (the “Interests”) for aggregate consideration of approximately $0.3 million in cash. The offer and sale of the Interests were made as part of Apollo IG Core’s continuous private offering and were exempt from the registration provisions of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2), including Regulation D and/or Regulation S thereunder.”

Pulmonx Corp issued 1,000,000 shares of warrant to Perceptive Credit Holdings V, LP.

“On the Closing Date, the Company issued to Perceptive a warrant to purchase up to 1,000,000 shares of the Company’s common stock, par value $0.001 per share, with an exercise price of $1.92 per share”

CytoDyn Inc. issued approximately 5.9 million shares of common stock of convertible note to holder of its convertible promissory note for notes with an aggregate principal amount of approximately $1.5 million.

“In January and February 2026, the Company and the holder of its convertible promissory note issued on April 23, 2021, in partial satisfaction of the holder’s redemption rights, entered into exchange agreements pursuant to which portions of the original note were partitioned into new notes with an aggregate principal amount of approximately $1.5 million. The new notes were exchanged concurrently with issuance for a total of approximately 5.9 million shares of common stock.”

CytoDyn Inc. issued approximately 0.8 million shares of common stock of common stock to YA II PN, Ltd. (Yorkville) for approximately $0.2 million in cash.

“In January 2026, pursuant to a Standby Equity Purchase Agreement (the “SEPA”) entered into on November 3, 2025, between the Company and YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”), the Company sold and issued to Yorkville a total of approximately 0.8 million shares of common stock in exchange for approximately $0.2 million in cash.”

CytoDyn Inc. issued 464,468 units of unit to accredited investor for $100,000 investment.

“On February 26, 2026, the Company accepted a $100,000 investment from an accredited investor in a transaction not involving a placement agent. The terms of the investment were identical to those of the Placement Agent Offering described above. Based on the deal price of $0.2153 per unit, the accredited investor received 464,468 units.”

CytoDyn Inc. issued 3,944,773 shares of common stock of common stock to accredited investor for approximately $1.0 million in cash.

“On January 23, 2026, in a private sale by the Company directly to an accredited investor, the Company issued a total of 3,944,773 shares of common stock in exchange for total gross cash proceeds to the Company of approximately $1.0 million.”

CytoDyn Inc. issued approximately 81.4 million units of unit to accredited investors through a placement agent for approximately $17.5 million in cash.

“On February 27, 2026, the Company concluded a private offering to accredited investors of units through a placement agent that commenced in January 2026 (the “Placement Agent Offering”). Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The purchase price per unit, $0.2153 (the “deal price”), was equal to 90% of the lower of the intraday volume weighted average prices of the common stock as of the first closing on January 30, 2026, and the final closing on February 27, 2026. As of the date of this filing, the Company has received binding subscription agreements to purchase a total of approximately 81.4 million units for a total of approximately $17.5 million in cash.”

Cuentas Inc. issued 714,286 Shares and a five-year warrant to purchase up to 714,286 shares of common stock to P.W. Janssen for aggregate gross proceeds of $300,000.

“On March 4, 2026, the Company issued and sold to Janssen the Shares and Warrant referred to in Item 1.01 above, for aggregate gross proceeds of $300,000. The exercise price of the Warrant is $0.42 per share, subject to anti-dilution adjustments.”

Cuentas Inc. issued 1,277,018 shares of the Company’s common stock of common stock to World Mobile Group Ltd. for conversion of promissory notes in the principal amount of $260,000.

“On February 25, 2026, World Mobile Group Ltd. (“WMG”) converted promissory notes of Cuentas, Inc. (the “Company”) in the principal amount of $260,000 (the “WMG Notes”) into 1,277,018 shares of the Company’s common stock, representing approximately 18.5% of the Company’s outstanding shares of common stock.”

Cuentas Inc. issued 714,286 share of the Company’s common stock (the “Shares”), and a five-year warrant to purchase up to 714,286 additional shares of common stock of common stock to P.W. Janssen for aggregate gross proceeds of $300,000 ($0.42 per unit).

“On February 26, 2026, the Company entered into a Securities Purchase Agreement with P.W. Janssen (“Janssen”), pursuant to which the Company issued and sold to Janssen 714,286 share of the Company’s common stock (the “Shares”), and a five-year warrant to purchase up to 714,286 additional shares of common stock (the “Warrant”) , for aggregate gross proceeds of $300,000 ($0.42 per unit).”

Cuentas Inc. issued 600,000 shares of its common stock of common stock to Spectrum Intelligence Communications Agency, LLC for equity component valued at $300,000 as part of satisfaction of a judgment.

“On February 24, 2026, Cuentas, Inc. (the “Company”) entered into a Confidential Conditional Satisfaction Agreement (the “Satisfaction Agreement”) with Spectrum Intelligence Communications Agency, LLC (“Spectrum”) relating to a judgment entered against the Company in the matter styled Spectrum Intelligence Communications Agency, LLC v. Limecom, Inc., Case No. 2018-027150-CA-01, in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida. Pursuant to the Satisfaction Agreement, Spectrum agreed to accept $650,000 as full satisfaction of the judgment, consisting of (i) $350,000 in cash and (ii) an equity component valued at $300,000. In connection with the equity component, the Company agreed to issue 600,000 shares of its common stock to Spectrum (or its designee), subject to the terms and conditions set forth in the Satisfaction Agreement.”

Vivakor, Inc. issued convertible note to the Lender (an accredited investor).

“As disclosed in Item 1.01, on October 8, 2025, we issued the Fourth Note to the Lender, which contains a standard Rule 144 restrictive legend. The issuance of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the Lender is an accredited investor and familiar with our operations based on representations in the Loan Agreement Amendment No. 3 and the Fourth Note.”

GoPro, Inc. issued up to 47,650,000 shares of Common Stock of convertible note to YA II PN, Ltd. (Yorkville) for $25,000,000 initial principal amount at 3% original issue discount.

“Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”) (as converted, the “Conversion Shares”). Pursuant to the Purchase Agreement, Yorkville purchased $25,000,000 in aggregate principal amount of Convertible Debentures on the signing of the Purchase Agreement (the “First Closing,” such date, the “First Closing Date”). Yorkville may purchase”

PINTEREST, INC. issued convertible note to Elliott Associates, L.P. and Elliott International, L.P. (collectively, "Elliott") for $1 billion in aggregate principal amount.

“the issuance and sale to Elliott of $1 billion in aggregate principal amount of the Company’s 1.75% Convertible Senior Notes due 2031”

Crypto Co issued 34,782,609 shares of common stock to Juan Betancourt for aggregate purchase price of $40,000.

“The Company agreed to sell and issue to the Investor 34,782,609 shares of the Company’s common stock, par value $0.001 (“ Common Stock ”) for an aggregate purchase price of $40,000.”

ExchangeRight Income Fund issued 14,749 of common stock for $ 405,000.

“Rule 506(c) of Regulation D promulgated thereunder. The following table details the shares sold: Number of Gross Share Class Shares Sold Proceeds Class D Common Shares 14,749 $ 405,000 Forward-Looking Statements Certain statements contained in this Current Report on Form 8-K other than historical facts may be considered “forward-looking statements,” and, as”

La Rosa Holdings Corp. issued 100 shares of preferred stock to institutional investor for $1,000 per share.

“the Company issued to the Investor 100 shares of the Company’s Series C Convertible Preferred Stock, par value $0.0001 per share (“ Series C Preferred Stock ”), for a purchase price of $1,000 per share.”

IPC Alternative Real Estate Income Trust, Inc. issued 6,471 shares of Class X-1 common stock of common stock to accredited investor for $150,000 aggregate purchase price.

“IPC Alternative Real Estate Income Trust, Inc. (the “Company”) issued 6,471 shares of Class X-1 common stock at a price per share of $23.1788 to an accredited investor in a private placement for an aggregate purchase price of $150,000.”

Nomadar Corp. issued up to 1,480,937 shares of Common Stock of common stock to an unaffiliated third-party accredited investor for $3.65 per share.

“agreed to sell, up to $5,405,417 of the Company’s class A common stock, par value $0.00001 per share (the “Common Stock”), in one or more closings, at a price per share equal to $3.65 (the “Per Share Purchase Price”), representing the issuance of up to 1,480,937 shares of Common Stock, in three separate tranches (the “Offering”). On March 3, 2026, the Company”

Franklin BSP Real Estate Debt, Inc. issued 310,607.06 shares of its Class G common stock, its Class G-D common stock, and its Class G-S common stock of common stock for at a price per Share detailed below plus applicable upfront selling commissions and placement fees.

“on March 2, 2026, the Company sold an aggregate of 310,607.06 shares of its Class G common stock, par value $0.001 per share (the “Class G Common Stock”), its Class G-D common stock, par value $0.001 per share (the “Class G-D Common Stock”), and its Class G-S common stock, par value $0.001 per share (the "Class G-S Common Stock" and together with the Class G Common Stock and Class G-D Common Stock, the "Shares"), at a price per Share detailed below plus applicable upfront selling commissions and placement fees.”

BlackRock Monticello Debt Real Estate Investment Trust issued 867,949.3965 common shares of common stock to third party investors and one or more officers, trustees, directors or employees of the Company’s investment advisers or their affiliates for aggregate consideration of $21,765,473, plus applicable upfront selling commissions and dealer manager fees.

“on March 2, 2026, the Company sold an aggregate of 867,949.3965 common shares (the “Shares”) for aggregate consideration of $21,765,473, plus applicable upfront selling commissions and dealer manager fees”

PIMCO Asset-Based Lending Co LLC issued 319,862 shares of common stock to third party investors for $3,300,000 aggregate.

“Shares - - Series II Anchor I Shares 1,004,880 $ 10,403,595 Anchor II Shares 715,851 7,392,265 Anchor III Shares 61,481 638,000 E Shares 24,188 251,572 Standard A Shares 319,862 3,300,000 (1) Inclusive of shares issued pursuant to the Company’s Distribution Reinvestment Plan. The offer and sale of Shares above were exempt from the registration provisions of the”